Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Watchful Waiting | 4 | 2023 | 492 | 1.950 |
Why?
|
Prostatic Neoplasms | 16 | 2024 | 11126 | 1.150 |
Why?
|
Seminoma | 1 | 2023 | 139 | 0.810 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2023 | 501 | 0.760 |
Why?
|
Testicular Neoplasms | 2 | 2023 | 806 | 0.710 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 808 | 0.560 |
Why?
|
Venous Thrombosis | 2 | 2023 | 1239 | 0.520 |
Why?
|
Gene Amplification | 4 | 2012 | 1063 | 0.490 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2023 | 2249 | 0.470 |
Why?
|
Carcinoma, Renal Cell | 3 | 2024 | 3143 | 0.430 |
Why?
|
Mexican Americans | 4 | 2007 | 165 | 0.430 |
Why?
|
Prostate | 5 | 2023 | 1775 | 0.420 |
Why?
|
Genomics | 6 | 2023 | 5717 | 0.410 |
Why?
|
Genetic Testing | 5 | 2024 | 3444 | 0.410 |
Why?
|
Genome, Human | 4 | 2013 | 4420 | 0.360 |
Why?
|
Thrombosis | 1 | 2023 | 2968 | 0.340 |
Why?
|
Pharmacogenetics | 2 | 2012 | 674 | 0.330 |
Why?
|
Education, Medical | 2 | 2011 | 1722 | 0.320 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4262 | 0.310 |
Why?
|
Clinical Medicine | 1 | 2009 | 147 | 0.310 |
Why?
|
Gene Dosage | 4 | 2009 | 1252 | 0.300 |
Why?
|
Disease Progression | 1 | 2023 | 13286 | 0.280 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2013 | 3921 | 0.250 |
Why?
|
Prostatic Hyperplasia | 2 | 2020 | 523 | 0.250 |
Why?
|
Germ-Line Mutation | 2 | 2024 | 1788 | 0.240 |
Why?
|
Prostatectomy | 3 | 2023 | 1890 | 0.240 |
Why?
|
Learning | 1 | 2013 | 1711 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2943 | 0.220 |
Why?
|
Prostate-Specific Antigen | 2 | 2023 | 2494 | 0.220 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2418 | 0.220 |
Why?
|
Curriculum | 2 | 2013 | 3605 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2850 | 0.210 |
Why?
|
Statistics as Topic | 1 | 2009 | 2373 | 0.210 |
Why?
|
Hematuria | 1 | 2023 | 235 | 0.210 |
Why?
|
Databases, Genetic | 1 | 2009 | 1783 | 0.200 |
Why?
|
Software | 3 | 2012 | 4441 | 0.200 |
Why?
|
DNA Copy Number Variations | 1 | 2009 | 1941 | 0.190 |
Why?
|
Asthma | 4 | 2007 | 6010 | 0.180 |
Why?
|
Linkage Disequilibrium | 1 | 2005 | 1997 | 0.180 |
Why?
|
Vena Cava, Inferior | 1 | 2023 | 440 | 0.180 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1438 | 0.170 |
Why?
|
Male | 27 | 2024 | 350115 | 0.170 |
Why?
|
Humans | 47 | 2024 | 744366 | 0.170 |
Why?
|
Computational Biology | 3 | 2013 | 3519 | 0.160 |
Why?
|
Taxoids | 1 | 2022 | 666 | 0.160 |
Why?
|
Thrombectomy | 1 | 2023 | 680 | 0.160 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2017 | 62 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2019 | 182 | 0.150 |
Why?
|
Gene Expression Profiling | 10 | 2024 | 9445 | 0.150 |
Why?
|
Nephrectomy | 1 | 2023 | 1050 | 0.150 |
Why?
|
Gene Expression | 1 | 2009 | 7798 | 0.140 |
Why?
|
Transcription Factors | 2 | 2012 | 12207 | 0.130 |
Why?
|
Colorectal Neoplasms | 2 | 2012 | 6773 | 0.130 |
Why?
|
DNA, Neoplasm | 4 | 2013 | 1758 | 0.120 |
Why?
|
Biopsy | 2 | 2023 | 6755 | 0.120 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 94 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2023 | 77460 | 0.110 |
Why?
|
Bronchodilator Agents | 3 | 2005 | 502 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 17446 | 0.100 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2012 | 197 | 0.100 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2013 | 221 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4185 | 0.100 |
Why?
|
Genes, Neoplasm | 1 | 2013 | 376 | 0.100 |
Why?
|
Genetic Markers | 3 | 2007 | 2634 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1486 | 0.100 |
Why?
|
E2F1 Transcription Factor | 1 | 2011 | 190 | 0.100 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 677 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2013 | 8432 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 14723 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2110 | 0.090 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2011 | 121 | 0.090 |
Why?
|
Behavior | 1 | 2013 | 561 | 0.090 |
Why?
|
Estradiol | 1 | 2017 | 2020 | 0.090 |
Why?
|
Puerto Rico | 3 | 2005 | 356 | 0.090 |
Why?
|
Estrogen Receptor alpha | 2 | 2017 | 577 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 4 | 2013 | 496 | 0.090 |
Why?
|
DNA Methylation | 3 | 2020 | 4285 | 0.090 |
Why?
|
Genotype | 6 | 2012 | 12952 | 0.080 |
Why?
|
Ki-67 Antigen | 1 | 2011 | 644 | 0.080 |
Why?
|
DNA-Binding Proteins | 3 | 2011 | 9647 | 0.080 |
Why?
|
Chromosome Aberrations | 3 | 2010 | 1813 | 0.080 |
Why?
|
Risk Adjustment | 1 | 2012 | 594 | 0.080 |
Why?
|
Genomic Instability | 2 | 2010 | 695 | 0.080 |
Why?
|
GATA6 Transcription Factor | 1 | 2008 | 50 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7721 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3646 | 0.080 |
Why?
|
Cell Line, Tumor | 7 | 2013 | 16690 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2011 | 1525 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2419 | 0.070 |
Why?
|
Ticlopidine | 1 | 2012 | 899 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2023 | 21748 | 0.070 |
Why?
|
Biliary Tract Neoplasms | 1 | 2008 | 178 | 0.070 |
Why?
|
DNA Helicases | 1 | 2011 | 861 | 0.070 |
Why?
|
Chromosome Inversion | 1 | 2006 | 127 | 0.070 |
Why?
|
Stromal Cells | 2 | 2024 | 1355 | 0.070 |
Why?
|
Genetics, Population | 2 | 2012 | 934 | 0.060 |
Why?
|
Cell Survival | 2 | 2012 | 5882 | 0.060 |
Why?
|
Receptors, Androgen | 2 | 2021 | 1058 | 0.060 |
Why?
|
Emigration and Immigration | 1 | 2007 | 402 | 0.060 |
Why?
|
RNA Interference | 4 | 2017 | 2890 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1351 | 0.060 |
Why?
|
Aged | 6 | 2023 | 163288 | 0.060 |
Why?
|
Albuterol | 1 | 2004 | 208 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2009 | 5856 | 0.060 |
Why?
|
Warfarin | 1 | 2012 | 1497 | 0.060 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 839 | 0.060 |
Why?
|
Pancreatic Neoplasms | 2 | 2013 | 5263 | 0.060 |
Why?
|
Anticoagulants | 2 | 2023 | 4600 | 0.060 |
Why?
|
Retroperitoneal Space | 1 | 2023 | 176 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2011 | 1988 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9240 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2009 | 2649 | 0.050 |
Why?
|
Middle Aged | 6 | 2023 | 213390 | 0.050 |
Why?
|
Immunoglobulin E | 2 | 2005 | 1463 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5511 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18373 | 0.050 |
Why?
|
Metalloendopeptidases | 1 | 2003 | 396 | 0.050 |
Why?
|
Multiprotein Complexes | 1 | 2008 | 1120 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11525 | 0.050 |
Why?
|
Genome | 1 | 2009 | 1807 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3590 | 0.050 |
Why?
|
BCG Vaccine | 1 | 2023 | 369 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2017 | 7882 | 0.050 |
Why?
|
Cohort Studies | 1 | 2023 | 40559 | 0.050 |
Why?
|
Androgens | 1 | 2008 | 1281 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 250 | 0.050 |
Why?
|
Forced Expiratory Volume | 1 | 2005 | 1745 | 0.050 |
Why?
|
Risk Assessment | 1 | 2021 | 23336 | 0.040 |
Why?
|
Soft Tissue Neoplasms | 1 | 2009 | 1363 | 0.040 |
Why?
|
Pedigree | 1 | 2007 | 4642 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 3070 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2917 | 0.040 |
Why?
|
Risk Factors | 2 | 2023 | 72296 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3922 | 0.040 |
Why?
|
Tissue Array Analysis | 2 | 2011 | 553 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13693 | 0.040 |
Why?
|
RNA, Small Interfering | 3 | 2013 | 3505 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2010 | 20824 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1262 | 0.040 |
Why?
|
Aromatase | 1 | 2017 | 147 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39052 | 0.040 |
Why?
|
Dihydrotestosterone | 1 | 2017 | 190 | 0.040 |
Why?
|
Genetic Variation | 1 | 2012 | 6542 | 0.040 |
Why?
|
Texas | 1 | 2017 | 391 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4839 | 0.040 |
Why?
|
Carcinoma | 1 | 2008 | 2375 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5172 | 0.030 |
Why?
|
United States | 4 | 2021 | 69872 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 713 | 0.030 |
Why?
|
Signal Transduction | 4 | 2024 | 23404 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3595 | 0.030 |
Why?
|
Mutation | 2 | 2012 | 29786 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2251 | 0.030 |
Why?
|
Chromosome Mapping | 3 | 2008 | 4740 | 0.030 |
Why?
|
Epigenomics | 1 | 2020 | 903 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2009 | 13104 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2013 | 73 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18034 | 0.030 |
Why?
|
Female | 10 | 2020 | 380193 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2013 | 11366 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2182 | 0.030 |
Why?
|
Mexico | 2 | 2005 | 689 | 0.030 |
Why?
|
Glycogen | 1 | 2013 | 259 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1213 | 0.030 |
Why?
|
Sirolimus | 1 | 2020 | 1565 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.030 |
Why?
|
Phenotype | 2 | 2010 | 16367 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2012 | 15520 | 0.030 |
Why?
|
Blotting, Western | 2 | 2009 | 5181 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2009 | 2715 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2013 | 355 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2949 | 0.020 |
Why?
|
Gene Library | 1 | 2013 | 1074 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2013 | 504 | 0.020 |
Why?
|
Search Engine | 1 | 2012 | 144 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2005 | 15535 | 0.020 |
Why?
|
Cell Proliferation | 3 | 2011 | 10483 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3464 | 0.020 |
Why?
|
Transfection | 1 | 2017 | 5895 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4554 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2009 | 351 | 0.020 |
Why?
|
Prognosis | 3 | 2021 | 29060 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1656 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2008 | 126 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
Gene Frequency | 2 | 2005 | 3587 | 0.020 |
Why?
|
Mice | 2 | 2012 | 81201 | 0.020 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2008 | 245 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2013 | 1127 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53290 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2011 | 634 | 0.020 |
Why?
|
Orchiectomy | 1 | 2009 | 474 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2008 | 380 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 13882 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2008 | 437 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13409 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8436 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15160 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4424 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1375 | 0.020 |
Why?
|
Adipokines | 1 | 2008 | 320 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2009 | 781 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 769 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2012 | 1431 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2891 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9312 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15078 | 0.020 |
Why?
|
Alleles | 2 | 2005 | 6933 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1950 | 0.010 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2004 | 201 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3616 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 2010 | 1149 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 21696 | 0.010 |
Why?
|
Animals | 2 | 2012 | 168768 | 0.010 |
Why?
|
Child | 3 | 2005 | 77709 | 0.010 |
Why?
|
Adolescent | 3 | 2005 | 85779 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4805 | 0.010 |
Why?
|
ADAM Proteins | 1 | 2003 | 243 | 0.010 |
Why?
|
Oncogenes | 1 | 2008 | 1265 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19233 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2009 | 1581 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15297 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8664 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9688 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57776 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2439 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2004 | 1617 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2383 | 0.010 |
Why?
|
Cell Cycle | 1 | 2008 | 2967 | 0.010 |
Why?
|
Glycoproteins | 1 | 2008 | 2266 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25039 | 0.010 |
Why?
|
Cell Lineage | 1 | 2008 | 2504 | 0.010 |
Why?
|
Leukocytes | 1 | 2006 | 2045 | 0.010 |
Why?
|
Haplotypes | 1 | 2004 | 2779 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12797 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5218 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4851 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20130 | 0.010 |
Why?
|
Regression Analysis | 1 | 2004 | 6459 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2008 | 5023 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 13035 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12788 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 63107 | 0.010 |
Why?
|
Apoptosis | 1 | 2008 | 9724 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9584 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5223 | 0.010 |
Why?
|
Adult | 1 | 2020 | 214052 | 0.000 |
Why?
|